American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Netflix
NFLX
|
+$348M |
| 2 |
Booking.com
BKNG
|
+$293M |
| 3 |
TSMC
TSM
|
+$239M |
| 4 |
Howmet Aerospace
HWM
|
+$231M |
| 5 |
Royal Caribbean
RCL
|
+$212M |
Top Sells
| 1 |
Apple
AAPL
|
+$570M |
| 2 |
Palantir
PLTR
|
+$375M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$235M |
| 4 |
Progressive
PGR
|
+$222M |
| 5 |
Salesforce
CRM
|
+$205M |
Sector Composition
| 1 | Technology | 26.45% |
| 2 | Financials | 14.55% |
| 3 | Consumer Discretionary | 12.69% |
| 4 | Industrials | 10.04% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Tejon Ranch
TRC
$447M
| $899K | ﹤0.01% |
52,988
+5,064
| +11% | +$85.9K |
|
2327
Kadant
KAI
$3.72B
| $888K | ﹤0.01% |
2,798
+207
| +8% | +$65.7K |
|
2328
America's Car Mart
CRMT
$282M
| $888K | ﹤0.01% |
15,840
+2,134
| +16% | +$120K |
|
2329
Monro
MNRO
$532M
| $884K | ﹤0.01% |
59,311
+3,903
| +7% | +$58.2K |
|
|
LENZ
2330
LENZ Therapeutics
LENZ
$1.16B
| $882K | ﹤0.01% |
30,109
-296
| -1% | -$8.68K |
|
2331
Johnson Outdoors
JOUT
$424M
| $882K | ﹤0.01% |
29,129
+12,040
| +70% | +$364K |
|
2332
RingCentral
RNG
$2.77B
| $881K | ﹤0.01% |
31,084
-6,936
| -18% | -$197K |
|
2333
Arcus Biosciences
RCUS
$1.23B
| $871K | ﹤0.01% |
107,052
+882
| +0.8% | +$7.18K |
|
2334
FTI Consulting
FCN
$5.28B
| $870K | ﹤0.01% |
5,389
-1,486
| -22% | -$240K |
|
2335
First Bancorp
FNLC
$304M
| $869K | ﹤0.01% |
34,202
+12
| +0% | +$305 |
|
2336
GameStop
GME
$11.5B
| $865K | ﹤0.01% |
35,473
+2,162
| +6% | +$52.7K |
|
2337
New Fortress Energy
NFE
$387M
| $864K | ﹤0.01% |
260,105
-279,321
| -52% | -$927K |
|
2338
First Community Corp
FCCO
$216M
| $862K | ﹤0.01% |
35,360
+15,161
| +75% | +$370K |
|
2339
Amylyx Pharmaceuticals
AMLX
$1.23B
| $861K | ﹤0.01% |
134,380
+27,366
| +26% | +$175K |
|
|
TSSI
2340
TSS, Inc. Common Stock
TSSI
$460M
| $861K | ﹤0.01% |
+29,849
| New | +$861K |
|
2341
Cytek Biosciences
CTKB
$513M
| $854K | ﹤0.01% |
251,273
+19,098
| +8% | +$64.9K |
|
2342
CRISPR Therapeutics
CRSP
$5.19B
| $854K | ﹤0.01% |
17,548
+112
| +0.6% | +$5.45K |
|
2343
First Foundation Inc
FFWM
$488M
| $850K | ﹤0.01% |
166,686
-160,055
| -49% | -$816K |
|
2344
The Honest Company
HNST
$455M
| $844K | ﹤0.01% |
165,893
-12,430
| -7% | -$63.3K |
|
2345
Primis Financial Corp
FRST
$272M
| $843K | ﹤0.01% |
77,669
-38,881
| -33% | -$422K |
|
|
QXO
2346
QXO Inc
QXO
$14.1B
| $837K | ﹤0.01% |
+38,843
| New | +$837K |
|
2347
Fresenius Medical Care
FMS
$14.5B
| $833K | ﹤0.01% |
29,173
+5,127
| +21% | +$146K |
|
2348
Arlo Technologies
ARLO
$1.85B
| $832K | ﹤0.01% |
49,039
| – | – |
|
2349
Fastly
FSLY
$1.32B
| $831K | ﹤0.01% |
117,655
-10,826
| -8% | -$76.4K |
|
2350
Charles River Laboratories
CRL
$7.51B
| $830K | ﹤0.01% |
5,469
+1,616
| +42% | +$245K |
|